SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-014227
Filing Date
2012-03-12
Accepted
2012-03-12 16:06:27
Documents
10
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v305080_10q.htm 10-Q 592182
2 CERTIFICATION v305080_ex31-1.htm EX-31.1 9372
3 CERTIFICATION v305080_ex31-2.htm EX-31.2 9660
4 CERTIFICATION v305080_ex32.htm EX-32 4787
  Complete submission text file 0001144204-12-014227.txt   2414784

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnbt-20120131.xml EX-101.INS 216025
6 XBRL TAXONOMY EXTENSION SCHEMA gnbt-20120131.xsd EX-101.SCH 21375
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnbt-20120131_cal.xml EX-101.CAL 52003
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnbt-20120131_def.xml EX-101.DEF 81317
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnbt-20120131_lab.xml EX-101.LAB 191143
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnbt-20120131_pre.xml EX-101.PRE 106575
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-25169 | Film No.: 12684070
SIC: 2834 Pharmaceutical Preparations